Best Peptides for Weight Loss in 2026

The Top Weight Loss Peptides Ranked

The peptide landscape for weight management has evolved dramatically. From first-generation GLP-1 agonists to cutting-edge triple agonists, the options available in 2026 are more effective than ever. This ranking is based on published clinical trial data, mechanism of action, and real-world considerations.

1. Tirzepatide (Dual GIP/GLP-1 Agonist)

Tirzepatide tops this list based on its combination of efficacy, FDA approval status, and growing real-world data. The SURMOUNT trials demonstrated up to 22.5% average body weight loss at the 15 mg dose, with over a third of participants losing 25% or more. Its dual GIP/GLP-1 mechanism provides superior metabolic effects compared to GLP-1-only approaches.

• Average weight loss: 15-22.5% (dose-dependent)
• Dosing: 2.5-15 mg weekly, titrated over 16+ weeks
• Administration: Once-weekly subcutaneous injection
• FDA status: Approved (Mounjaro for T2D, Zepbound for obesity)
• Key advantage: Best FDA-approved weight loss efficacy currently available

2. Retatrutide (Triple GIP/GLP-1/Glucagon Agonist)

Retatrutide would arguably be number one if it were FDA-approved, given its superior phase 2 trial results. The addition of glucagon receptor activation increases metabolic rate and provides exceptional liver fat reduction. However, it remains in phase 3 trials.

• Average weight loss: 17.5-24.2% (dose-dependent, phase 2 data)
• Dosing: 4-12 mg weekly, titrated over 12+ weeks
• Administration: Once-weekly subcutaneous injection
• FDA status: Phase 3 clinical trials (expected 2026-2027)
• Key advantage: Highest weight loss ever recorded in clinical trials; exceptional liver fat reduction

3. Semaglutide (GLP-1 Receptor Agonist)

Semaglutide remains the most widely used and well-studied weight loss peptide. Its STEP trial data, cardiovascular outcome benefits (SELECT trial), and years of real-world use provide the deepest evidence base. It is the safe, proven choice.

• Average weight loss: 15-17% at maintenance dose
• Dosing: 0.25-2.4 mg weekly, titrated over 16 weeks
• Administration: Once-weekly subcutaneous injection
• FDA status: Approved (Wegovy for obesity, Ozempic for T2D)
• Key advantage: Most clinical data, proven cardiovascular benefits

4. AOD-9604 (GH Fragment)

AOD-9604 takes a completely different approach -- targeting fat metabolism through the growth hormone pathway without affecting appetite, blood sugar, or hormonal balance. Its weight loss is more modest than GLP-1 agonists but comes with minimal side effects.

• Average weight loss: Modest (clinical trials showed statistically significant but smaller effects than GLP-1 agonists)
• Dosing: 300 mcg daily, subcutaneous
• Administration: Daily injection, morning on empty stomach
• FDA status: Not approved (TGA-approved as food supplement ingredient in Australia)
• Key advantage: Clean side effect profile, no GI issues, no hormonal disruption

5. CJC-1295/Ipamorelin Stack (GH Secretagogues)

This GH secretagogue combination promotes fat loss indirectly through elevated growth hormone levels. GH increases lipolysis (fat breakdown) and preserves lean mass during caloric restriction. The fat loss effects are moderate compared to GLP-1 agonists but come with additional benefits (improved sleep, skin, recovery).

• Average weight loss: Moderate (primarily fat loss with lean mass preservation)
• Dosing: CJC-1295 100 mcg + Ipamorelin 100-200 mcg, 1-3x daily
• Administration: Subcutaneous injection on empty stomach
• Key advantage: Body recomposition (fat loss + muscle preservation), sleep improvement

How to Choose: Decision Framework

• Maximum weight loss with FDA backing: Tirzepatide
• Most proven track record: Semaglutide
• Research-stage but potentially superior: Retatrutide
• Fat loss with minimal side effects: AOD-9604
• Overall body composition improvement: CJC-1295/Ipamorelin

Using the Peptide Calculator for Weight Loss Peptides

The Peptide Calculator Plus supports all five of these peptides. For GLP-1 agonists, the calculator shows milligram-level dosing with titration support. For AOD-9604 and the GH secretagogue stack, it handles microgram-level precision. Enter your vial strength and reconstitution volume to get exact syringe units for any dose.